American Journal of Hematology

Papers
(The H4-Index of American Journal of Hematology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Issue Information456
The insertion site is the main risk factor for central venous catheter‐related complications in patients with hematologic malignancies261
Basiliximab for steroid‐refractory acute graft‐versus‐host disease: A real‐world analysis227
A t(6;14;9)(p22;q22;q34) three‐way translocation: Description of a cytogenetically visible variant t(6;9) in acute myeloid leukemia154
Characteristics and prevalence of antibiotic allergies in patients with sickle cell disease: A single‐center retrospective study146
Clonal hematopoiesis in patients with Covid‐19 is stable and not linked to an aggravated clinical course146
Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry data141
Hemolysis after high‐dose intravenous immunoglobulin: An under‐appreciated sequelae131
Natural killer cells: Innate immune system as a part of adaptive immunotherapy in hematological malignancies126
107
Cytopenias revealing a case of carcinocythemia with bone marrow metastasis95
CORRIGENDUM85
Aspirin use in essential thrombocythemia: Once‐daily or twice‐daily or not at all?83
Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis81
The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases76
Primary Effusion Lymphoma Prognostic Score (PEL‐PS): A Validated International Prognostic Score in HIV‐Associated Primary Effusion Lymphoma74
Are veterans at increased risk of myeloproliferative neoplasms?71
Dendritic cell vaccines extend CAR T‐cell persistence and improve the efficacy of CD19 CAR T‐cell therapy in refractory or relapsed adult B‐ALL patients70
Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemia69
Acute thrombocytopenia suggesting thrombotic microangiopathy66
65
The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms63
The latest insights into rare blood disorders: Diagnosis and treatment strategies61
Muscular de‐conditioning and reduced cardiac inotropism due to iron deposition reduce exercise tolerance in beta thalassemia major60
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers60
Overall Survival in Male Patients With Advanced Hematological Disease (Mostly Acute Leukemia) Is Influenced by CYP1B1 C432G Polymorphism and Donor Sex in Allogeneic Stem Cell Transpl59
Oh node: Extranodal nodular involvement of chronic lymphocytic leukemia in the colon59
Antibody response to COVID‐19 mRNA vaccine (Comirnaty) in myeloma patients treated with high‐dose melphalan and/or immunotherapy56
Teclistamab in patients with multiple myeloma and impaired renal function55
Therapeutic Errors Associated With Antithrombotic Medications Reported to United States Poison Centers55
Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic Leukemia53
Ruxolitinib for refractory large granular lymphocyte leukemia52
Intravenous Iron Associated Hypophosphatemia: Much More Than a Laboratory Curiosity50
Not All Tryptase Elevations Are due to Acquired Clonal Mast Cell Disorders: When Tryptase Gene Copy Number Analysis Becomes Critical49
Clonal Hematopoiesis and Thrombosis47
Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome46
Introduction to American Journal of Hematology Supplement: Improving Initial Care for Acute GVHD Patients46
The impact of sex on platelet responses to aspirin in patients with peripheral artery disease45
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia44
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations44
Age defining immune effector cell associated neurotoxicity syndromes in aggressive large B cell lymphoma patients treated with axicabtagene ciloleucel43
R‐miniCHOP versus R‐CHOP in elderly patients with diffuse large B‐cell lymphoma: A propensity matched population‐based study43
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML43
0.086302042007446